University of California, San Francisco: Sclerosis trials

The registry lists 10 Sclerosis studies with University of California, San Francisco as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 2 2Phase 3 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Non-invasive Transcranial Electrical Stimulation in MSCompletedNCT04466228Not applicableResults posted
• Digital Cognition in Multiple SclerosisCompletedNCT03569618Not applicableResults posted
• A TSEC for Symptom Management in Menopausal Women With Multiple SclerosisCompletedNCT02710214Phase 2Results posted
• Neuroprotection With Riluzole Patients With Early Multiple SclerosisCompletedNCT00501943Phase 2Results posted
• Melatonin for Sleep in MSCompletedNCT04035889Not applicable
• Coaching and Activity Tracking in Multiple Sclerosis - A Pilot StudyCompletedNCT03335618Not applicable
• Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)CompletedNCT02365922
• Environmental and Genetic Risk Factors for Pediatric Multiple SclerosisCompletedNCT01396343
• Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple SclerosisCompletedNCT00819195
• A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose NaltrexoneCompletedNCT00501696Phase 3